Ekin, A. Et Al. 2024. Effectiveness and Safety Data in Rheumatoid Arthritis Patients after Switching from Originator Rituximab to Biosimilar Rituximab (CT-P10). AKTUELLE RHEUMATOLOGIE , no.50 , 1-2.

Ekin, A., Mısırcı, S., Lermi, N., Dik Kutlu, N., Coşkun, B. N., Yağız, B., ... Dalkılıç, H. E.(2024). Effectiveness and Safety Data in Rheumatoid Arthritis Patients after Switching from Originator Rituximab to Biosimilar Rituximab (CT-P10). AKTUELLE RHEUMATOLOGIE , no.50, 1-2.

Ekin, ALİ Et Al. "Effectiveness and Safety Data in Rheumatoid Arthritis Patients after Switching from Originator Rituximab to Biosimilar Rituximab (CT-P10)," AKTUELLE RHEUMATOLOGIE , no.50, 1-2, 2024

Ekin, ALİ Et Al. "Effectiveness and Safety Data in Rheumatoid Arthritis Patients after Switching from Originator Rituximab to Biosimilar Rituximab (CT-P10)." AKTUELLE RHEUMATOLOGIE , no.50, pp.1-2, 2024

Ekin, A. Et Al. (2024) . "Effectiveness and Safety Data in Rheumatoid Arthritis Patients after Switching from Originator Rituximab to Biosimilar Rituximab (CT-P10)." AKTUELLE RHEUMATOLOGIE , no.50, pp.1-2.

@article{article, author={ALİ EKİN Et Al. }, title={Effectiveness and Safety Data in Rheumatoid Arthritis Patients after Switching from Originator Rituximab to Biosimilar Rituximab (CT-P10)}, journal={AKTUELLE RHEUMATOLOGIE}, year=2024, pages={1-2} }